IP Library Granted Patent US 9,968,721
Granted Patent B2
US 9,968,721 · App. 14/554,338 · Granted May 15, 2018

Monitoring fluid volume for patients with renal disease

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,968,721
App. No.
14/554,338
Granted
May 15, 2018
Kind
B2
Abstract

A method includes monitoring an indicator of fluid volume of a patient via a sensor device, and setting an initial fluid volume removal prescription for a blood fluid removal session based on the monitored indicator of fluid volume. The method may further include transmitting data regarding the indicator of fluid volume from the implantable sensor device to fluid removal device. The system includes a blood fluid removal device and control electronics configured to set the initial fluid removal volume and rate prescription. In some embodiments, the fluid removal device sets or calculated the initial fluid volume removal prescription based on the data received from the implantable sensor. The indicator of fluid volume may be an indicator of tissue fluid volume or an indicator of blood fluid volume.

Claims (29)

1. A method comprising

monitoring an indicator of fluid volume of a patient via a sensor device wherein the indicator of fluid volume is interstitial fluid impedance;

monitoring an indicator of blood fluid volume;

setting an initial fluid volume removal prescription for a blood fluid removal session based on the monitored indicators of interstitial fluid volume and blood fluid volume.

2. The method of claim 1 , further comprising transmitting data regarding the indicator of fluid volume and the indicator of blood fluid volume from the sensor device to a fluid removal device.

3. The method of claim 2 , wherein setting the initial fluid volume removal prescription comprises calculating the fluid volume prescription by the fluid removal device based on the data received from the sensor.

4. The method of claim 2 , wherein the fluid removal device is implantable.

5. The method of claim 2 , wherein the fluid removal device is wearable.

6. The method of claim 1 , further comprising determining whether the indicator of fluid volume crosses a predetermined threshold value, and providing an alert to the patient if the indicator of fluid volume is determined to cross the threshold value.

7. The method of claim 1 , further comprising:

determining whether the monitored indicator of fluid volume crosses a predetermined threshold; and

providing a sensory cue to the patient if the monitored indicator is determined to cross the threshold.

8. The method of claim 1 , wherein the sensor device comprises:

a detector circuit and components configured to acquire sensed data regarding an indicator of fluid volume; and

control electronics configured to receive the acquired sensed data from the detector circuit and to calculate a fluid volume removal prescription based on the acquired sensed data.

9. The method of claim 8 , wherein the control electronics comprise a computer readable medium that, when implemented, cause the electronics to calculate the initial fluid rate removal prescription based on data received from the sensor and instruct the fluid rate removal controller to operate according to the initial fluid rate removal prescription.

10. A sensor device comprising:

a detector circuit and components configured to acquire sensed data regarding an indicator of fluid volume;

control electronics configured to receive the acquired sensed data from the detector circuit and to calculate a fluid volume removal prescription based on the acquired sensed data; wherein

the sensor device is configured to carry out the method of claim 8 .

11. The method of claim 1 , wherein setting an initial fluid volume removal prescription comprises a setting a volume rate of a replacement fluid that is added to a patient's blood.

12. The method of claim 1 , further comprising setting an initial fluid rate removal prescription for the blood fluid removal session based on the monitored indicator of fluid volume.

13. The method of claim 12 , setting the initial fluid rate removal prescription comprises calculating the fluid rate removal prescription by a fluid removal device based on the data received from the sensor.

14. The method of claim 1 , wherein the sensor is configured to measure interstitial fluid impedance at a first location; and further comprising:

measuring interstitial fluid impedance at a second location; and

determining whether the impedance measured at the first location and the impedance measured at the second location differ by a predetermined amount.

15. The method of claim 1 , wherein the sensor device is implantable.

16. The method of claim 1 , wherein the sensor device is wearable.

17. The method of claim 1 , wherein the initial fluid volume removal prescription is based on a ratio of the monitored indicators of interstitial fluid volume and blood fluid volume.

Assignments (3)
SECURITY INTEREST Recorded Dec 1, 2025
From: MOZARC MEDICAL US LLC
To: ORBIMED ROYALTY & CREDIT OPPORTUNITIES V, LP
Reel/Frame 073800/0164 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 19, 2023
From: MEDTRONIC, INC.
To: MOZARC MEDICAL US LLC
Reel/Frame 063375/0659 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 12, 2015
From: GERBER, MARTIN; BYRNES, JOHN; LYU, SUPING; MANDA, VENKATESH; PUDIL, BRYANT
To: MEDTRONIC, INC.
Reel/Frame 034681/0032 →